摘要 |
The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. It further relates to the compounds herein and their pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof useful in treating diseases, disorders, syndromes and/or conditions associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. The invention also relates to process for the preparation of the compounds of the invention. |
申请人 |
Lupin Limited |
发明人 |
RAMDAS, Vidya;LORIYA, Rajeshkumar, Maganlal;WALKE, Deepak, Sahebrao;DAS, Amit, Kumar;KHAN, Talha, Hussain;BANERJEE, Moloy;PALLE, Venkata, P.;KAMBOJ, Rajender, Kumar |